UnknownNot Applicable

Safety and Efficacy of Immages System in Patients Recieving IV Therapy

Israel50 participantsStarted 2013-11

Plain-language summary

The study will evaluate the functionality of IMMAGES , an intravenous infusion device system, in patients hospitalized in Bait Balev hospital. The study will aim to determine how the IMMAGES system integrates within IV infusion therapy regime and what are the advantages and disadvantages, if any, of using this system within the prescribed setting.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients requiring infusion therapy
✓. Patients receiving infusion therapy by gravity flow or by pump
✓. patients are scheduled to receive at least once a day an infusion therapy
✓. Patients are scheduled to receive an infusion therapy for at least 3 days
✓. Adult over age of 18 years
✓. Informed consent form signed by patient.

Exclusion criteria

✕. Informed consent form not signed
✕. Patients are scheduled to receive less than once a day an infusion therapy
✕. patients to receive less than 3 days of infusion therapy
✕. patients not hospitalized in a ward that is participating in the study.
✕. patients participating in another clinical study or clinical field test
✕. Patients require isolation treatment

What they're measuring

Successful operation of IMMAGES defined by patient receiving the prescribed IV medication using the IMMAGES system , openning of the controller valve including using the smartphone application and the management software

Timeframe: as long as the patient is reciving the IV prescribed medication, and no longer than 10 days

Trial details

NCT IDNCT02020811

SponsorPRo-IV

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-04

Contact for this trial

Gizele Sasson, MD

972-52-4425581

View on ClinicalTrials.gov More Sepsis trials